Minerva Neurosciences, Inc. (NERV)
4.05
+0.15
(+3.85%)
USD |
NASDAQ |
Jan 23, 12:45
Minerva Neurosciences Free Cash Flow: -14.20M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| iBio, Inc. | -17.30M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.916M |
| Cash from Financing (Quarterly) | -0.0452M |
| Free Cash Flow Per Share (Quarterly) | -0.3853 |
| Free Cash Flow to Equity (Quarterly) | -2.916M |
| Free Cash Flow to Firm (Quarterly) | -2.916M |
| Free Cash Flow Yield | -46.31% |